Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,535Revenue (TTM) $M1,227Net Margin (%)-3.6Altman Z-Score3.5
Enterprise Value $M3,504EPS (TTM) $-0.1Operating Margin %-7.1Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.4Pre-tax Margin (%)-6.5Higher ROA y-yN
Price/Book1.710-y EBITDA Growth Rate %--Quick Ratio1.6Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %--Current Ratio1.7Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %240ROA % (ttm)-1.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-2.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M559ROIC % (ttm)-2.1Gross Margin Increase y-yN

Gurus Latest Trades with OPK

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

OPK is held by these investors:



OPK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2017-07-26Buy36,200$6.39-1.1view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2017-07-25Buy39,800$6.41-1.4view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2017-07-24Buy45,000$6.42-1.56view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2017-07-20Buy5,400$6.46-2.17view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2017-07-17Buy1,800$6.044.64view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2017-07-14Buy12,600$6.162.6view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2017-07-12Buy3,600$6.123.27view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2017-07-10Buy50,000$6.192.1view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2017-07-06Buy25,000$6.290.48view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2017-07-03Buy60,800$6.44-1.86view

Press Releases about OPK :

Quarterly/Annual Reports about OPK:

News about OPK:

Articles On GuruFocus.com
Stocks That Fell to 3-Year Lows in the Week of July 14 Jul 16 2017 
OPKO Health Announces KDIGO Clinical Practice Guideline Update on CKD-MBD Jun 22 2017 
OPKO’S GeneDx Extends Relationship with University of California Health for Genetic and Molecul Jun 07 2017 
OPKO Health Provides Commercial Update for RAYALDEE Jun 05 2017 
Weekly CEO Buys Highlight May 29 2017 
MabVax Therapeutics Announces the Closing of its $4.1 Million Public Offering May 22 2017 
OPKO Announces Multiple Presentations at the 112th American Urological Association Annual Meeting May 15 2017 
Weekly CEO Buys Highlights May 15 2017 
CORRECTION -- OPKO Health Inc. May 09 2017 
OPKO Health Reports 2016 Financial and Operating Results May 09 2017 

More From Other Websites
OPKO Health, Inc. breached its 50 day moving average in a Bullish Manner : OPK-US : July 20, 2017 Jul 20 2017
Xenetic Biosciences Announces Adjournment of Annual Meeting of Stockholders until Wednesday, August... Jul 18 2017
ETFs with exposure to OPKO Health, Inc. : July 18, 2017 Jul 18 2017
Today's Research Reports on Stocks to Watch: CEL-SCI Corporation and Opko Health Jul 03 2017
Edited Transcript of OPK earnings conference call or presentation 9-May-17 8:30pm GMT Jun 29 2017
ETFs with exposure to OPKO Health, Inc. : June 26, 2017 Jun 26 2017
How Things Look for Opko Health, Inc. in 3 Charts Jun 26 2017
Xenetic Biosciences Commences Patient Enrollment in Phase 2 Study Evaluating XBIO-101 in Conjunction... Jun 26 2017
OPKO Health Announces KDIGO Clinical Practice Guideline Update on CKD-MBD Jun 22 2017
OPKO Health, Inc. breached its 50 day moving average in a Bullish Manner : OPK-US : June 22, 2017 Jun 22 2017
OPKO Provides Update to Topline Data of Phase 3 Clinical Study of hGH-CTP in Growth Hormone... Jun 15 2017
OPKO Health, Inc. :OPK-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 Jun 14 2017
Today's Research Reports on Stocks to Watch: Exelixis and Opko Health Jun 13 2017
OPKO’S GeneDx Extends Relationship with University of California Health for Genetic and Molecular... Jun 07 2017
OPKO Health Provides Commercial Update for RAYALDEE Jun 05 2017
Here's Why Opko Health Inc. Slipped 18.8% in May Jun 05 2017
James J. Martin Appointed as Chief Financial Officer of Cocrystal Pharma, Inc. Jun 01 2017
Is the Options Market Predicting a Spike in Opko Health (OPK) Stock? May 25 2017
3 Value Stocks You Might Not Have Thought Of May 25 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}